相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity
Yane C. P. Andrade et al.
BEHAVIOURAL PHARMACOLOGY (2021)
Decreased Brain pH and Pathophysiology in Schizophrenia
Hae-Jeong Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Novel rare variations in genes that regulate developmental change in N-methyl-D-aspartate receptor in patients with schizophrenia
Akane Yoshikawa et al.
HUMAN GENOME VARIATION (2018)
Cyclin-dependent Kinase 5: Novel role of gene variants identified in ADHD
Subhamita Maitra et al.
SCIENTIFIC REPORTS (2017)
Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: basal contents and effects of psychotropic medications
Alfredo Ramos-Miguel et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition
Olivia Engmann et al.
BRAIN (2011)
Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons
P Kerokoski et al.
NEUROSCIENCE LETTERS (2004)